Zelira Therapeutics Limited logo

ZLDZelira Therapeutics Limited

ZLD Stock Price, Valuation & Chart | Zelira Therapeutics Limited

Compare

ZLD Historical price chart

ZLD Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization6.57M
PE Ratio-1.58
EPS-0.32
Trading Volume19.14K
Today's High/Low0.5/0.48
Dividend Yield0.00
52 Week High/Low1.15/0.31
Shares Outstanding13.15M
ZLD Financial Statement

ZLD Analyst ratings

Buy

Strong buy
0
Buy
0
Hold
0
Sell
0
Strong sell
0

Based on 0 analysts giving stock ratings to ZLD in the past 3 months.

ZLD Analysis & performance metrics

ZLD Company profile

Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialisation of cannabinoid-based medicines for the treatment of…

ZLD Management team

Management
Oludare OdumosuCEO
MD, Global Chief Executive Officer & Director
Rahul Ganesan
Vice President of Finance & Accounting
Osagie O. Imasogie Esq.
Founder & Chairman
Patty Washer
Clinical Trial Consultant
Timothy Ryan SlateCTO
Company Secretary & Non-Executive Director
Greg BlakeCTO
Executive Director
Total 6 executives

ZLD Frequently asked questions

What is Zelira Therapeutics Limited (ZLD) Stock Price?

Current stock price of Zelira Therapeutics Limited (ZLD) stock is $0.500. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Zelira Therapeutics Limited (ZLD) stock is 19.14K.

Last updated at 27 Feb 2026, 04:55 am.

Why is the Zelira Therapeutics Limited (ZLD) stock price going up or down today?

The stock price of Zelira Therapeutics Limited (ZLD) can change with earnings, company news, and overall market sentiment. Zelira Therapeutics Limited operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Zelira Therapeutics Limited stock expensive at its current price?

Whether Zelira Therapeutics Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ZLD on this page is -1.58. EPS on this page is -0.32. Compare those figures with peers and growth expectations before deciding if the current Zelira Therapeutics Limited price is justified.

How has the stock price of Zelira Therapeutics Limited (ZLD) performed historically?

Historical performance for Zelira Therapeutics Limited (ZLD) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ZLD reacted to past earnings and market events.

Should I buy Zelira Therapeutics Limited (ZLD) stock, at this price?

Buying Zelira Therapeutics Limited (ZLD) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.